Day 1
Thursday, 17th November
15.30 IMPaCT, a Spanish Precision Medicine Initiative
Chair: Dídac Mauricio
Welcome
Genomics in the IMPaCT Spanish Personalized Medicine Infrastructure
Mónica Bayes, CNAG
The IMPaCT-T2D Initiative
Silvia Bonàs-Guarch, Center for Genomic Regulation
16.30 COFFEE BREAK
17.00 Keynote lectures
Chair: Urko Martínez
Human Genetics in T2D Drug Discovery and Development: A Tale from AstraZeneca’s Genomics Initiative
Slavé Petrovski, Centre for Genomics Research, AstraZeneca
Embracing the complexity of complex disease
Marylyn D. Ritchie, University of Pennsylvania
18.00 END OF FIRST DAY
Day 2
Friday, 18th November
9.00 Genomic insights into Mendelian Diabetes
Chair: Luis Castaño
Modeling non-coding genome defects underlying diabetes
Jorge Ferrer, Center for Genomic Regulation
Correctly identifying and treating pathogenic coding variants causing monogenic diabetes
Andrew Hattersley, University of Exeter
10.20 COFFEE BREAK
10.50 Leveraging complex trait genetics for predictive medicine
Chair: Arcadi Navarro
The genetic of human height, a model complex trait
Peter Visscher, University of Queensland
Translational genomics of cardiometabolic traits
Eleftheria Zeggini, Helmholtz Zentrum München
From GWAS to function - strategies to gain mechanistic disease insight
Danielle Posthuma, Vrije Universiteit Amsterdam
12.50 LUNCH
14.00 Genomics and precision medicine for common forms of diabetes
Chair: Ana M. Wägner
Type 1 diabetes genetic risk scores for improved classification and prediction of diabetes
Richard Oram, University of Exeter
Towards precision medicine in diabetes: using genetics to understand disease heterogeneity
José Flórez, University of Harvard
15.20 Closing
15.30 END OF THE SYMPOSIUM
CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes